The road to wellness: The task of getting lifesaving medical isotopes to patients

February 2, 2024, 3:01PMNuclear NewsTim Gregoire
A vial of Ac-225 produced by Niowave stands next to its lead shipping pig. (Photo: Niowave)

According to the Council on Radionuclides and Radiopharmaceuticals, more than 82,000 nuclear imaging procedures using nuclear medicine are performed throughout the world every day. To administer these vital medical procedures, radiopharmaceutical companies and hospitals rely on a handful of producers of medical radioisotopes.

Canadian-German joint venture to produce medical Ac-225

October 23, 2023, 9:30AMNuclear News

German-based radiopharmaceutical biotech company ITM Isotope Technologies Munich and Canadian Nuclear Laboratories are launching a new joint venture company for the industrial-scale production of actinium-225, which is used in targeted alpha therapies to fight cancer. The new company is being called Actineer.

DOE accelerates evaluation of new medical radioisotopes

April 13, 2022, 12:00PMNuclear News

The Department of Energy announced on April 11 that it will distribute $1 million to three awardees to evaluate newly developed radioisotopes for potential therapeutic use in preclinical and clinical trials. The funding is provided by the DOE Isotope Program, which produces isotopes for use in science, medicine, and industry that would otherwise be unavailable or in short supply.

An inventive solution speeds up production of actinium-225

August 5, 2021, 12:00PMNuclear News
Chemist Kevin Gaddis has adapted components of a high-pressure ion chromatography system to withstand the extreme conditions of a hot cell. (Photo: ORNL/Carlos Jones)

An Oak Ridge National Laboratory researcher has built a device that can speed up the separation of the medical radioisotope actinium-225 from irradiated thorium targets and withstand the high-radiation environment of a hot cell. In July, ORNL announced that Kevin Gaddis, a chemistry technician at the lab, had built and tested a prototype and was working to secure a patent for a device that cut separations time by 75 percent.